These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29510924)

  • 1. Schizophrenia-like olfactory dysfunction induced by acute and postnatal phencyclidine exposure in rats.
    Shan L; Liu T; Zhang Z; Liu Q; Zhang M; Zhao X; Zhang Y; Xu F; Ma Y
    Schizophr Res; 2018 Sep; 199():274-280. PubMed ID: 29510924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia.
    Wang C; McInnis J; Ross-Sanchez M; Shinnick-Gallagher P; Wiley JL; Johnson KM
    Neuroscience; 2001; 107(4):535-50. PubMed ID: 11720778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Male rats treated with subchronic PCP show intact olfaction and enhanced interest for a social odour in the olfactory habituation/dishabituation test.
    Tarland E; Brosda J
    Behav Brain Res; 2018 Jun; 345():13-20. PubMed ID: 29477413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs.
    Cochran SM; Kennedy M; McKerchar CE; Steward LJ; Pratt JA; Morris BJ
    Neuropsychopharmacology; 2003 Feb; 28(2):265-75. PubMed ID: 12589379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult response to olanzapine or clozapine treatment is altered by adolescent antipsychotic exposure: a preclinical test in the phencyclidine hyperlocomotion model.
    Shu Q; Hu G; Li M
    J Psychopharmacol; 2014 Apr; 28(4):363-75. PubMed ID: 24257809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postnatal Phencyclidine (PCP) as a Neurodevelopmental Animal Model of Schizophrenia Pathophysiology and Symptomatology: A Review.
    Grayson B; Barnes SA; Markou A; Piercy C; Podda G; Neill JC
    Curr Top Behav Neurosci; 2016; 29():403-428. PubMed ID: 26510740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic risperidone exposure does not show any evidence of bone mass deterioration in animal model of schizophrenia.
    Petronijevic N; Sopta J; Doknic M; Radonjic N; Petronijevic M; Pekic S; Maric N; Jasovic-Gasic M; Popovic V
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():58-63. PubMed ID: 23811489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone reverses phencyclidine induced decrease in glutathione levels and alterations of antioxidant defense in rat brain.
    Stojković T; Radonjić NV; Velimirović M; Jevtić G; Popović V; Doknić M; Petronijević ND
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):192-9. PubMed ID: 22735395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.
    McLean SL; Grayson B; Idris NF; Lesage AS; Pemberton DJ; Mackie C; Neill JC
    Eur Neuropsychopharmacol; 2011 Apr; 21(4):333-43. PubMed ID: 20630711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in aripiprazole sensitization from adolescence to adulthood.
    Freeman E; Lin J; Chow S; Davis C; Li M
    Pharmacol Biochem Behav; 2017 May; 156():39-47. PubMed ID: 28389140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting.
    Broberg BV; Glenthøj BY; Dias R; Larsen DB; Olsen CK
    Psychopharmacology (Berl); 2009 Nov; 206(4):631-40. PubMed ID: 19390843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phencyclidine decreases tickling-induced 50-kHz ultrasound vocalizations in juvenile rats: a putative model of the negative symptoms of schizophrenia?
    Boulay D; Ho-Van S; Bergis O; Avenet P; Griebel G
    Behav Pharmacol; 2013 Oct; 24(7):543-51. PubMed ID: 23928693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in gene expression after phencyclidine administration in developing rats: a potential animal model for schizophrenia.
    Liu F; Zou X; Sadovova N; Zhang X; Shi L; Guo L; Qian F; Wen Z; Patterson TA; Hanig JP; Paule MG; Slikker W; Wang C
    Int J Dev Neurosci; 2011 May; 29(3):351-8. PubMed ID: 20691775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance.
    Pedersen CS; Goetghebeur P; Dias R
    J Neurosci Methods; 2009 Dec; 185(1):66-9. PubMed ID: 19761795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelination deficit in a phencyclidine-induced neurodevelopmental model of schizophrenia.
    Zhang R; He J; Zhu S; Zhang H; Wang H; Adilijiang A; Kong L; Wang J; Kong J; Tan Q; Li XM
    Brain Res; 2012 Aug; 1469():136-43. PubMed ID: 22750584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.
    Abdul-Monim Z; Neill JC; Reynolds GP
    J Psychopharmacol; 2007 Mar; 21(2):198-205. PubMed ID: 17329300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacological evaluations of novel olanzapine analogues in rats: a potential new avenue for the treatment of schizophrenia.
    Jafari S; Huang XF; Andrews JL; Fernandez-Enright F
    PLoS One; 2013; 8(12):e80979. PubMed ID: 24349027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment.
    Mouri A; Noda Y; Enomoto T; Nabeshima T
    Neurochem Int; 2007; 51(2-4):173-84. PubMed ID: 17669558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm.
    Abdul-Monim Z; Reynolds GP; Neill JC
    Behav Brain Res; 2006 May; 169(2):263-73. PubMed ID: 16500717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scents and nonsense: olfactory dysfunction in schizophrenia.
    Turetsky BI; Hahn CG; Borgmann-Winter K; Moberg PJ
    Schizophr Bull; 2009 Nov; 35(6):1117-31. PubMed ID: 19793796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.